Thomas Unger is a Senior Consultant with Cutter Consortium’s Data Analytics & Digital Technologies practice. He is also Associate Director of Arthur D. Little (ADL)'s US Healthcare and Lifesciences Practice. Mr. Unger specializes in complex problem solving in the biopharmaceutical, med-tech and healthcare sectors. He has extensive experience leading programs and teams as they envision and successfully develop innovative digital and technology enabled solutions for strategic, operational and transformational products and services. Thomas has created a number of cross-industry and cross-stakeholder partnerships that brought together disparate data and analytics to resolve key healthcare industry challenges.
Thomas helped initiate the NEWDIGS program at MIT’s Center for Biomedical Innovation, and is an advisor to Massachusetts General Center for Assessment Technology and Continuous Health. He serves as a scientific advisor to an early stage company applying ML/AI to large data sets and advanced analytics in pharma/biotech manufacturing.
Mr. Unger has previously held a number of senior roles in pharma and medtech companies, including a number of years at Pfizer Inc.. He received his PhD in Biological Chemistry from the University of California, Irvine, and an MBA from the University of Southern California's Marshall School of Business. He can be reached at firstname.lastname@example.org.